Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.

Siddiqui MB, Patel S, Bhati C, Reichman T, Williams K, Driscoll C, Liptrap E, Rinella ME, Sterling RK, Siddiqui MS.

Transplant Proc. 2019 Jul - Aug;51(6):1895-1901. doi: 10.1016/j.transproceed.2019.04.062.

PMID:
31399173
2.

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores.

Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K.

Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41130-X. doi: 10.1053/j.gastro.2019.07.033. [Epub ahead of print]

PMID:
31356807
3.

Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.

Gordon SW, McGuire WP 3rd, Shafer DA, Sterling RK, Lee HM, Matherly SC, Roberts JD, Bose P, Tombes MB, Shrader EE, Ryan AA, Kmieciak M, Nguyen T, Deng X, Bandyopadhyay D, Dent P, Poklepovic AS.

Am J Clin Oncol. 2019 Aug;42(8):649-654. doi: 10.1097/COC.0000000000000567.

PMID:
31305287
4.

Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults.

Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG; HIV-HBV Cohort Study of the Hepatitis B Research Network.

Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]

PMID:
31220357
5.

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.

Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Rajender Reddy K, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW.

J Hepatol. 2019 May 13. pii: S0168-8278(19)30278-8. doi: 10.1016/j.jhep.2019.04.016. [Epub ahead of print]

PMID:
31096006
6.

Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.

Bajaj JS, Salzman NH, Acharya C, Sterling RK, White MB, Gavis EA, Fagan A, Hayward M, Holtz ML, Matherly S, Lee H, Osman M, Siddiqui MS, Fuchs M, Puri P, Sikaroodi M, Gillevet PM.

Hepatology. 2019 Apr 30. doi: 10.1002/hep.30690. [Epub ahead of print]

PMID:
31038755
7.

Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.

Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF; Hepatitis B Research Network (HBRN).

PLoS Pathog. 2019 Apr 18;15(4):e1007715. doi: 10.1371/journal.ppat.1007715. eCollection 2019 Apr.

8.

Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.

Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N; Hepatitis B Research Network (HBRN).

J Viral Hepat. 2019 Jul;26(7):856-865. doi: 10.1111/jvh.13104. Epub 2019 May 2.

PMID:
30974509
9.

Adherence to Recommended Inpatient Hepatic Encephalopathy Workup.

Kumral D, Qayyum R, Roseff S, Sterling RK, Siddiqui MS.

J Hosp Med. 2019 Mar;14(3):157-160. doi: 10.12788/jhm.3152.

PMID:
30811321
10.

Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.

Siddiqui MB, Arshad T, Patel S, Lee E, Albhaisi S, Sanyal AJ, Stravitz RT, Driscoll C, Sterling RK, Reichman T, Bhati C, Siddiqui MS.

Hepatology. 2019 Jul;70(1):98-107. doi: 10.1002/hep.30518. Epub 2019 Mar 29.

PMID:
30672598
11.

Jaccoud's Arthropathy and Jaundice in a Young Woman.

Issa D, Hatfield B, Sterling RK.

Clin Gastroenterol Hepatol. 2018 Dec 14. pii: S1542-3565(18)31383-1. doi: 10.1016/j.cgh.2018.12.009. [Epub ahead of print] No abstract available.

PMID:
30557734
12.

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.

Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG; HIV-HBV Cohort Study of the Hepatitis B Research Network.

Am J Gastroenterol. 2019 May;114(5):746-757. doi: 10.1038/s41395-018-0409-9.

PMID:
30410040
13.

Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease.

An K, Starkweather A, Sturgill J, Salyer J, Sterling RK.

Nurs Res. 2019 Jan/Feb;68(1):29-38. doi: 10.1097/NNR.0000000000000319.

PMID:
30247335
14.

Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy.

Gupta G, Zhang Y, Carroll NV, Sterling RK.

Am J Transplant. 2018 Oct;18(10):2496-2505. doi: 10.1111/ajt.15054. Epub 2018 Aug 30.

PMID:
30075489
15.

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.

Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N, Lim JK, Reddy KR, Di Bisceglie AM, Fried MW.

PLoS One. 2018 Aug 1;13(8):e0196908. doi: 10.1371/journal.pone.0196908. eCollection 2018.

16.

Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.

Redman JS, Sterling RK.

Am J Gastroenterol. 2018 Nov;113(11):1585-1587. doi: 10.1038/s41395-018-0201-x. Epub 2018 Jul 24.

PMID:
30038424
17.

Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.

Bajaj JS, Acharya C, Fagan A, White MB, Gavis E, Heuman DM, Hylemon PB, Fuchs M, Puri P, Schubert ML, Sanyal AJ, Sterling RK, Stravitz TR, Siddiqui MS, Luketic V, Lee H, Sikaroodi M, Gillevet PM.

Am J Gastroenterol. 2018 Aug;113(8):1177-1186. doi: 10.1038/s41395-018-0085-9. Epub 2018 Jun 6.

PMID:
29872220
18.

Treatment of HCV in the Department of Corrections in the Era of Oral Medications.

Sterling RK, Cherian R, Lewis S, Genther K, Driscoll C, Martin K, Goode MB, Matherly S, Siddiqui MS, Luketic VA, Stravitz RT, Puri P, Lee H, Smith P, Patel V, Sanyal AJ.

J Correct Health Care. 2018 Apr;24(2):127-136. doi: 10.1177/1078345818762591. Epub 2018 Mar 22.

PMID:
29566611
19.

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.

Evon DM, Amador J, Stewart P, Reeve BB, Lok AS, Sterling RK, Di Bisceglie AM, Reau N, Serper M, Sarkar S, Lim JK, Golin CE, Fried MW.

Aliment Pharmacol Ther. 2018 Apr;47(7):1001-1011. doi: 10.1111/apt.14531. Epub 2018 Jan 29.

20.

Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.

Patel SS, Nabi E, Guzman L, Abbate A, Bhati C, Stravitz RT, Reichman T, Matherly SC, Driscoll C, Lee H, Luketic VA, Sterling RK, Sanyal AJ, Patel V, Levy M, Siddiqui MS.

Liver Transpl. 2018 Mar;24(3):333-342. doi: 10.1002/lt.25012.

21.

Mechanisms of liver disease in patients infected with HIV.

Kaspar MB, Sterling RK.

BMJ Open Gastroenterol. 2017 Oct 26;4(1):e000166. doi: 10.1136/bmjgast-2017-000166. eCollection 2017. Review.

22.

Brain Integrity Changes Underlying Cognitive and Functional Recovery Postliver Transplant Continue to Evolve Over 1 Year.

Ahluwalia V, Wade JB, White MB, Gilles HS, Heuman DM, Fuchs M, Gavis EA, Fagan A, Thacker LR, Sterling RK, Stravitz RT, Puri P, Sanyal AJ, Siddiqui MS, Matherly S, Luketic V, Steinberg J, Moeller FG, Bajaj JS.

Transplantation. 2018 Mar;102(3):461-470. doi: 10.1097/TP.0000000000001991.

23.

Administration of crushed ledipasvir-sofosbuvir tablets via gastrostomy button in a patient coinfected with HIV and hepatitis C virus.

Fulco PP, Sterling RK, Lavoie SR.

Am J Health Syst Pharm. 2017 Nov 1;74(21):1761-1762. doi: 10.2146/ajhp170452. No abstract available.

PMID:
29070496
24.

Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.

Catron TD, Smallfield GB, Kang L, Sterling RK, Siddiqui MS.

Dig Dis Sci. 2017 Nov;62(11):3091-3099. doi: 10.1007/s10620-017-4671-2. Epub 2017 Jul 12.

PMID:
28702754
25.

The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions.

Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling RK, White MB, Ignudo C, Bommidi S, DeSoto J, Thacker LR, Matherly S, Shaw J, Siddiqui MS, Puri P, Sanyal AJ, Luketic V, Lee H, Stravitz RT, Bajaj JS.

Liver Int. 2017 Dec;37(12):1843-1851. doi: 10.1111/liv.13494. Epub 2017 Jul 5.

PMID:
28618192
26.

Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B.

Hassan MA, Kim WR, Li R, Smith CI, Fried MW, Sterling RK, Ghany MG, Wahed AS, Ganova-Raeva LM, Roberts LR, Lok ASF; Hepatitis B Research Network.

Am J Epidemiol. 2017 Aug 1;186(3):356-366. doi: 10.1093/aje/kwx064.

27.

Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment.

Evon DM, Golin CE, Stewart P, Fried MW, Alston S, Reeve B, Lok AS, Sterling RK, Lim JK, Reau N, Sarkar S, Nelson DR, Reddy KR, Di Bisceglie AM.

Contemp Clin Trials. 2017 Jun;57:58-68. doi: 10.1016/j.cct.2017.03.013. Epub 2017 Mar 22.

28.

Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.

Bhati C, Idowu MO, Sanyal AJ, Rivera M, Driscoll C, Stravitz RT, Kohli DR, Matherly S, Puri P, Gilles H, Cotterell A, Levy M, Sterling RK, Luketic VA, Lee H, Sharma A, Siddiqui MS.

Transplantation. 2017 Aug;101(8):1867-1874. doi: 10.1097/TP.0000000000001709.

PMID:
28296807
29.

Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.

Patidar KR, Thacker LR, Wade JB, White MB, Gavis EA, Fagan A, Sterling RK, Fuchs M, Siddiqui MS, Matherly S, Stravitz RT, Sanyal AJ, Puri P, Luketic VA, Bajaj JS.

Dig Dis Sci. 2017 May;62(5):1173-1179. doi: 10.1007/s10620-017-4509-y. Epub 2017 Mar 3.

PMID:
28258378
30.

Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.

Bajaj JS, Fagan A, Sikaroodi M, White MB, Sterling RK, Gilles H, Heuman D, Stravitz RT, Matherly SC, Siddiqui MS, Puri P, Sanyal AJ, Luketic V, John B, Fuchs M, Ahluwalia V, Gillevet PM.

Liver Transpl. 2017 Jul;23(7):907-914. doi: 10.1002/lt.24754.

31.

Developing a new algorithm to diagnose advanced liver fibrosis: A lift or a nudge in the right direction?

Adams LA, Sterling RK.

J Hepatol. 2017 Jun;66(6):1111-1113. doi: 10.1016/j.jhep.2017.02.011. Epub 2017 Feb 17. No abstract available.

PMID:
28219771
32.

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.

Acharya C, Betrapally NS, Gillevet PM, Sterling RK, Akbarali H, White MB, Ganapathy D, Fagan A, Sikaroodi M, Bajaj JS.

Aliment Pharmacol Ther. 2017 Jan;45(2):319-331. doi: 10.1111/apt.13858. Epub 2016 Nov 20.

33.

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.

Bajaj JS, Sterling RK, Betrapally NS, Nixon DE, Fuchs M, Daita K, Heuman DM, Sikaroodi M, Hylemon PB, White MB, Ganapathy D, Gillevet PM.

Aliment Pharmacol Ther. 2016 Sep;44(6):638-43. doi: 10.1111/apt.13732. Epub 2016 Jul 15.

34.

Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS norms.

Bajaj JS, White MB, Unser AB, Ganapathy D, Fagan A, Gavis EA, Sterling RK, Heuman DM, Matherly S, Puri P, Sanyal AJ, Luketic V, Fuchs M, Siddiqui MS, Stravitz RT, John B, Thacker LR, Wade JB.

Metab Brain Dis. 2016 Oct;31(5):1199-203. doi: 10.1007/s11011-016-9860-8. Epub 2016 Jun 25.

35.

Liver transplantation significantly improves global functioning and cerebral processing.

Ahluwalia V, Wade JB, White MB, Gilles HS, Heuman DM, Fuchs M, Gavis EA, Fagan A, Tinsley F, Ganapathy D, Thacker LR, Sterling RK, Stravitz RT, Puri P, Sanyal AJ, Siddiqui MS, Matherly S, Luketic V, Steinberg J, Moeller FG, Bajaj JS.

Liver Transpl. 2016 Oct;22(10):1379-90. doi: 10.1002/lt.24498.

36.

Editorial: A New Spin on Magnetic Resonance Elastography.

Kishore R, Loomba R, Sterling RK.

Am J Gastroenterol. 2016 Jun;111(6):834-7. doi: 10.1038/ajg.2016.134.

PMID:
27249983
37.

Recombination among GB virus C (GBV-C) isolates in the United States.

Blackard JT, Ma G, Polen C, DuBois JC, Gast J, Radens CM, Sterling RK, Sherman KE.

J Gen Virol. 2016 Jul;97(7):1537-44. doi: 10.1099/jgv.0.000477. Epub 2016 Apr 11.

38.

Hyperbilirubinaemia in HIV-HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?

Kaspar MB, Sterling RK.

BMJ Open Gastroenterol. 2016 Mar 2;3(1):e000072. doi: 10.1136/bmjgast-2015-000072. eCollection 2016.

39.

Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM; Hepatitis B Research Network.

Gastroenterology. 2016 Mar;150(3):684-695.e5. doi: 10.1053/j.gastro.2015.11.050. Epub 2015 Dec 10.

40.

In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving.

Lauridsen MM, Thacker LR, White MB, Unser A, Sterling RK, Stravitz RT, Matherly S, Puri P, Sanyal AJ, Gavis EA, Luketic V, Siddiqui MS, Heuman DM, Fuchs M, Bajaj JS.

Clin Gastroenterol Hepatol. 2016 May;14(5):747-52. doi: 10.1016/j.cgh.2015.11.007. Epub 2015 Nov 19.

41.

De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.

Idowu MO, Chhatrala R, Siddiqui MB, Driscoll C, Stravitz RT, Sanyal AJ, Bhati C, Sargeant C, Luketic VA, Sterling RK, Contos M, Matherly S, Puri P, Siddiqui MS.

Liver Transpl. 2015 Nov;21(11):1395-402. doi: 10.1002/lt.24223.

42.

The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.

Ahluwalia V, Wade JB, Moeller FG, White MB, Unser AB, Gavis EA, Sterling RK, Stravitz RT, Sanyal AJ, Siddiqui MS, Puri P, Luketic V, Heuman DM, Fuchs M, Matherly S, Bajaj JS.

Liver Transpl. 2015 Sep;21(9):1123-32. doi: 10.1002/lt.24163. Epub 2015 Jul 21.

43.

Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.

Siddiqui MS, Cheang KL, Luketic VA, Boyett S, Idowu MO, Patidar K, Puri P, Matherly S, Stravitz RT, Sterling RK, Sanyal AJ.

Dig Dis Sci. 2015 Aug;60(8):2529-37. doi: 10.1007/s10620-015-3627-7. Epub 2015 Mar 18.

44.

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM.

Aliment Pharmacol Ther. 2015 Apr;41(7):671-85. doi: 10.1111/apt.13095. Epub 2015 Jan 28.

45.

Treatment of hepatitis C, then, now and tomorrow.

Sterling RK, Dharel N.

Evid Based Med. 2015 Feb;20(1):23. doi: 10.1136/ebmed-2014-110103. Epub 2014 Dec 30. No abstract available.

PMID:
25550483
46.

Chronic liver disease in the human immunodeficiency virus patient.

Acharya C, Dharel N, Sterling RK.

Clin Liver Dis. 2015 Feb;19(1):1-22. doi: 10.1016/j.cld.2014.09.001. Epub 2014 Oct 29. Review.

PMID:
25454294
47.

Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.

Patel AV, Wade JB, Thacker LR, Sterling RK, Siddiqui MS, Stravitz RT, Sanyal AJ, Luketic V, Puri P, Fuchs M, Matherly S, White MB, Unser A, Heuman DM, Bajaj JS.

Clin Gastroenterol Hepatol. 2015 May;13(5):987-91. doi: 10.1016/j.cgh.2014.09.049. Epub 2014 Oct 28.

48.

Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.

Dharel N, Sterling RK.

Gastroenterol Hepatol (N Y). 2014 Dec;10(12):780-8.

49.

Utility of evaluating HCV in an uninsured population.

Donepudi I, Paredes A, Hubbard S, Awad C, Sterling RK.

Dig Dis Sci. 2015 Apr;60(4):1092-7. doi: 10.1007/s10620-014-3416-8. Epub 2014 Nov 5.

PMID:
25371153
50.

Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.

Siddiqui MS, Fuchs M, Idowu MO, Luketic VA, Boyett S, Sargeant C, Stravitz RT, Puri P, Matherly S, Sterling RK, Contos M, Sanyal AJ.

Clin Gastroenterol Hepatol. 2015 May;13(5):1000-8.e3. doi: 10.1016/j.cgh.2014.10.008. Epub 2014 Oct 13.

Supplemental Content

Loading ...
Support Center